Fred Grossman - Jan 9, 2025 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Medical Officer
Signature
/s/ David Snyder, Attorney-in-Fact
Stock symbol
COYA
Transactions as of
Jan 9, 2025
Transactions value $
$0
Form type
4
Date filed
1/13/2025, 08:00 AM
Previous filing
Nov 12, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +141K $0.00 141K Jan 9, 2025 Common Stock, par value $0.0001 per share 141K $6.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date.